Seeing Is Believing
Currently out of the existing stock ratings of Eddie Hickman, 24 are a BUY (96%), 1 are a HOLD (4%).
Analyst Eddie Hickman, currently employed at GUGGENHEIM, carries an average stock price target met ratio of 56.67% that have a potential upside of 101.32% achieved within 248 days.
Eddie Hickman’s has documented 40 price targets and ratings displayed on 5 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on GHRS, GH Research PLC at 07-Aug-2026.
Analyst best performing recommendations are on ISEE (IVERIC BIO).
The best stock recommendation documented was for ISEE (IVERIC BIO) at 9/7/2022. The price target of $35 was fulfilled within 236 days with a profit of $20.06 (134.27%) receiving and performance score of 5.69.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 24-Jan-2020
$40
3 years 4 months 14 days ago
(08-May-2023)
4/5 (80%)
$8.4 (26.58%)
470
Buy Since 02-Aug-2022
$34
$-5.95 (-14.89%)
$26
3 years 4 months 19 days ago
(03-May-2023)
2/3 (66.67%)
$-3.21 (-8.63%)
116
Hold Since 02-May-2023
$35
$-4.95 (-12.39%)
$35
3 years 4 months 20 days ago
(02-May-2023)
5/6 (83.33%)
$-2.72 (-7.21%)
247
Buy Since 04-Aug-2021
$35
$-4.95 (-12.39%)
3 years 4 months 21 days ago
(01-May-2023)
1/2 (50%)
$-3.05 (-8.02%)
42
Buy Since 02-Mar-2022
$40
$0.05 (0.13%)
$34
3 years 4 months 21 days ago
(01-May-2023)
2/3 (66.67%)
$1.95 (5.12%)
318
Which stock is Eddie Hickman most bullish on?
What Year was the first public recommendation made by Eddie Hickman?